Beximco Pharma to Acquire Eight ANDAs from Sandoz Inc.


-- February 20, 2019

Beximco Pharmaceuticals Limited ("Beximco Pharma", "BPL" or "the Company"; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces the signing of a definitive agreement with Sandoz Inc., a division of Novartis, to acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the US for an undisclosed amount in cash.

Beximco Pharma’s current US portfolio comprises six US Food and Drug Administration (FDA) approved products. Four of these products are currently being exported to the US and two products are awaiting regulatory approval. Following this transaction, Beximco Pharma’s US portfolio will consist of 14 approved ANDAs.

Nazmul Hassan MP, Managing Director of Beximco Pharmaceuticals, commented: “The acquisition of these ANDAs from Sandoz, a global leader in the generics market, significantly strengthens our position in the US, expanding our portfolio to 14 approved products. The acquisition is expected to provide a major boost to our export sales in the future and we look forward to continuing to build our presence in this important strategic market for Beximco Pharma.”

In August 2016, Beximco Pharma became the first Bangladeshi pharmaceutical company to export medicine to the US market following its manufacturing site approval by the US FDA in June 2015.

Beximco Pharma is a leading exporter of pharmaceuticals in Bangladesh. The Company currently has a global footprint in more than 50 countries and has been accredited by the leading global regulatory authorities including the US FDA, AGES (EU), TGA (Australia), Health Canada, GCC (Gulf) and TFDA (Taiwan).

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.


X

Proyash


...
  • A specialized institute that works for the holistic development of children with special educational needs through different programs
  • Include early childhood development programs (ECD), special schooling, therapeutic interventions, medical and neuro-developmental assessment, leisure time and co-curricular activities, training for the teachers, parents and integrated services


Other CSR Initiatives


... ...
  • Charity contributions through the Gono Sahajjo Songstha (GSS) for the educational sector for the unprivileged
  • Free drugs during natural calamities and distribution of clothing during winter
  • As part of BEXIMCO Group’s focus on society development, Fazlur Rahman Foundation has established a project called "FRF Diagnostic Centre". The project provides health screening services for Beximco Pharmaceuticals and Beximco Antibiotics Industries employees.
  • Sponsoring events and national sport stars and teams
  • Official sponsor of the Bangladesh National Cricket team for the ICC Cricket World Cup 2011
  • Official sponsor of the FIFA friendly match between Argentina and Nigeria held in September, 2011